Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Different PCOS subgroups have similar metabolic features, but those without menstrual problems have milder issues.

PRP therapy is effective for hair regrowth and improving hair quality with minimal side effects.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

The combination of oral finasteride and dutasteride with topical minoxidil effectively promotes new hair growth in most people, with minimal side effects.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Cyclosporine improved skin condition in dogs with sebaceous adenitis.

Using minoxidil with finasteride in a cream helps maintain hair thickness after stopping oral finasteride.

Topical treatments like AHAs, BHAs, and urea may help keratosis pilaris, but evidence is limited.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Minoxidil and finasteride combo maintains hair density effectively.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Genetic variants in CYP genes may worsen PCOS symptoms.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.